Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy


Aggressive pituitary tumors (APTs) are associated with significant morbidity and mortality, and effective treatment options are limited. Immune checkpoint inhibitors (ICIs) have revolutionized clinical cancer care; however, there is little experience with these agents in the management of APTs. Vascular endothelial growth factor (VEGF) targeted therapy has reported success in a small number of APT case reports. Here we describe a case of pituitary carcinoma responding to ICI therapy and subsequently VEGF inhibition. We discuss the possible mechanisms and experience with ICI therapy and VEGF inhibitors in the management of APTs, biomarkers that may predict response, and the potential role of combination therapies including ICIs and temozolomide.

Type Journal
ISBN 1664-2392 (Print) 1664-2392 (Linking)
Authors Lamb, L. S.; Sim, H. W.; McCormack, A. I.
Responsible Garvan Author Dr Ann McCormack
Publisher Name Frontiers in Endocrinology
Published Date 2020-11-30
Published Volume 11
Published Pages 576027
Status Published in-print
DOI 10.3389/fendo.2020.576027
URL link to publisher's version